• subtypes
  • As of September 2015[update], it is in phase 3 clinical trials for the treatment influenza due to its inhibitory effect on a broad range of influenza virus subtypes and efficacy against influenza viruses that are resistant to neuraminidase inhibitors like tamiflu. (wikipedia.org)
  • harmless
  • These reports resulted in a brief debate in medical journals in the early 1990s between some physicians in the United States who believed that Blastocystis was harmless, and physicians in the United States and overseas who believed it could cause disease. (wikipedia.org)
  • The presence of E.coli is not cause in and of itself to seek treatment as it is considered harmless. (wikipedia.org)
  • diarrhea
  • Evidence exists for its use in the preventative treatment of antibiotic-associated diarrhea (AAD) in adults. (wikipedia.org)
  • The study compared nitazoxanide and probiotics in the treatment of acute rotavirus diarrhea. (wikipedia.org)
  • They found Small differences in favor of nitazoxanide in comparison with probiotics and concluded that nitazoxanide is an important treatment option for rotavirus diarrhea. (wikipedia.org)
  • He correctly described how the bacteria caused diarrhea, and developed treatments that were found to be effective. (wikipedia.org)
  • nitazoxanide
  • Research perspective: potential role of nitazoxanide in ovarian cancer treatment. (wikipedia.org)
  • Nitazoxanide is a broad-spectrum antiparasitic drug and FDA-approved PFOR inhibitor which is used for the treatment of Giardiasis and Cryptosporidiosis. (wikipedia.org)
  • Nitazoxanide has gone through Phase II clinical trials for the treatment of hepatitis C, in combination with peginterferon alfa-2a and ribavirin. (wikipedia.org)
  • role
  • Although the role of Blastocystis hominis in human disease is often referred to as controversial, a systematic survey of research studies conducted by 11 infectious disease specialists from nine countries, found that over 95% of papers published in the 10 years prior identified it as causing illness in immunocompetent individuals. (wikipedia.org)
  • drugs
  • Between 1975 and 1999 only 13 of 1,300 new drugs were antiparasitics, which raised concerns that insufficient incentives existed to drive development of new treatments for diseases that disproportionately target low-income countries. (wikipedia.org)
  • However
  • However, in our experience, the most successful treatment is the one developed by Professor Tom Borody at the Centre of Digestive Disorders (CDD) in Sydney, Australia. (burghwoodclinic.co.uk)